Peptide Therapy and Cancer Risk: What's Actually Known About BPC-157, Growth Hormone Peptides, and More

Claim: "Peptide therapy" is a safe, cutting-edge wellness tool

Instagram and TikTok accounts promote injectable peptides like BPC-157, TB-500, GHK-Cu, and growth-hormone compounds like ipamorelin and CJC-1295. They're marketed for muscle recovery, wound healing, anti-aging, and "longevity."

They're framed as the next frontier of self-optimization, sold like advanced supplements. What's rarely mentioned: most aren't FDA-approved drugs. Online vendors sell them as "research chemicals not for human consumption." This label is used to sell them without FDA approval. People inject them anyway.

What these compounds actually are

BPC-157 is a synthetic peptide from a protein fragment found in the stomach. It has shown healing in animal studies but hasn't finished human trials the FDA requires for approval. TB-500, GHK-Cu, and growth-hormone compounds fall into the same category. They look promising in animal studies but lack large human trials showing long-term safety, including cancer risk.

Since they're not regulated, there's no guarantee of purity, correct dosing, or sterility. A vial could contain more, less, or something other than the label says.

Is there a real cancer connection?

Here the honest answer is "an open question," not "yes" or "no." Growth-hormone compounds raise concern most. They increase growth hormone and insulin-like growth factor 1 (IGF-1). IGF-1 is a normal hormone that controls cell growth and division. That's why researchers have studied hormone pathways and cancer for decades. Hormones shape cancer risk by affecting cell growth. Estrogen, a hormone in growth pathways, is a known carcinogen at certain exposure levels. IGF-1 hasn't been shown to cause cancer in humans. But scientists have asked whether long-term high IGF-1 could help cancer cells grow. This is a real research question, not proof. It's not proof these peptides cause cancer in people.

For BPC-157, GHK-Cu, and TB-500, there's no real human data on long-term cancer risk. They haven't been tracked in long human trials that would show a cancer signal. They've never gone through FDA approval requiring that monitoring.

Where the marketing goes wrong

The main problem with "peptide therapy" posts isn't claims that they cause cancer. Most don't mention cancer. The problem is implied safety: presenting unapproved, unregulated compounds as normal wellness upgrades, with no mention that regulators haven't checked them and no note that these pathways are studied for cancer risk.

"No evidence of cancer risk" is not "proven safe." For most, the honest statement is that safety—including cancer risk—hasn't been answered yet. Long-term human studies are missing.

The bigger picture

This doesn't mean everyone who tried these peptides has cancer risk. There's no data showing that. These products are sold ahead of the evidence and marketed with more confidence than science supports. Anyone considering an unregulated peptide should treat it like an unapproved drug. Talk to a doctor. Know there's no quality control and "not proven dangerous" is not "proven safe." Those with cancer history or higher risk should talk to an oncologist before using these compounds.

Sources

• NCI — Cancer Risk Factors
• NCI — Hormones and Cancer Risk
• U.S. Food and Drug Administration
• Instagram reel (@errett_peptides)

How this article was prepared

An AI-assisted editorial system helped prepare this page. No named medical reviewer has reviewed it unless one is listed.

Cancer Explained is published by the National Cancer Information Foundation. It is not medical advice and does not suggest a test or treatment.

See an error, old source, or unclear wording? Tell us.